This white paper provides Medical Affairs professionals with the background and history of Real-World Evidence, and its applications in the biopharma industry to benefit patients.
How do leaders make their way to Medical Safety & Pharmacovigilance? The routes are diverse but one constant remains true: They are extremely committed to being an independent voice that amplifies their organization’s commitment to Patient Centricity.
Digitalization offers Medical Affairs teams the opportunity to rethink strategy and actions across the lifecycle of traditional and nontraditional products.
This podcast previews the MAPS 2022 Global Annual Meeting session “How Medical Affairs can best support internal and external collaborations in patient engagement,” that details the unique role of Medical Affairs in patient engagement.
One of the pandemic’s silver linings may well be gains in participation levels and the volume and quality of insights generated by eliminating the constraints of face-to-face interaction.
In this podcast, we speak with presenters of the MAPS 2022 Global Annual Meeting session, “Developing and Executing and Integrated Medical Communications Strategy and Plan.”
This webinar will feature 5 medical heads providing a scorecard on how Medical Affairs throughout the APAC region have performed, given the challenging environment of the global pandemic. Based on this analysis, our expert speakers will then share their expectations and wishlists for the near future for Patients, Healthcare Community and our Industry.
Attendees of this webinar will gain insights into the following key areas:
This podcast, part two of a two-part series, discusses practical tips on how to incorporate cybersecurity into your own practices and devices.
In this final article in the Leadership Perspectives series, John Pracyk interviews J&J leaders to explore a bold vision of career development that entails moving across sectors; namely, crossing over between Pharmaceuticals, Medical Devices, Vision, and Consumer Health.
In conversation with John Pracyk, MD, PhD, MBA, Medical Affairs leaders from Johnson & Johnson describe best practices to prepare our next generation of Chief Medical Officers.